Effective management of high blood pressure could prevent more than 518,000 annual cardiovascular deaths worldwide, according to preliminary modeling research presented at the American Heart Association’s Hypertension Scientific Sessions 2026 in Arlington, Virginia.
Models Project Global Mortality Across Twenty Countries
Researchers examined health data across 20 countries chosen for having the highest numbers of deaths from non-communicable diseases. The modeling analysis evaluated potential reductions in mortality if six evidence-based preventive services reached approximately 80% of eligible patients, matching performance levels seen in high-performing healthcare systems in the United States. Non-communicable diseases account for roughly three out of five deaths globally, with approximately 73% of those fatalities occurring in low- or middle-income nations.
Researchers at the Johns Hopkins University School of Medicine spearheaded the modeling analysis, which evaluated how scaling up six evidence-based preventive care measures—blood pressure management, statin therapy for elevated cholesterol, blood sugar regulation for diabetic individuals, and screenings for cervical, breast, and colon cancers—might alter health outcomes.
According to Scott Pilla, M.D., M.H.S., an associate professor of medicine at Johns Hopkins University School of Medicine, the team analyzed existing data to determine if expanding non-communicable disease preventive healthcare services across 20 countries worldwide could reduce cardiovascular death. No lower-income countries were included among the 20 analyzed nations.
Out of all evaluated interventions, improving blood pressure control averted the highest number of projected deaths, saving an estimated 518,476 lives annually. Expanding statin treatment for high cholesterol was projected to prevent 340,682 deaths, while optimizing blood sugar management for people with Type 1 or Type 2 diabetes could prevent 309,520 deaths each year.
Data Reveals Where Improvement Opportunities Stand Out Most
The analysis revealed substantial gaps in care across all participating nations, though lower-middle-income countries harbor the largest opportunities for clinical gains. Improved blood pressure control alone could prevent 223,655 deaths annually in lower-middle-income countries and 223,282 deaths in upper-middle-income countries.
Scott Pilla, Associate Professor of Medicine at Johns Hopkins University School of Medicine, highlighted particular opportunities in some countries for improvement.
Current delivery rates fall short.
Only about one in five adults with hypertension in the studied countries maintains controlled blood pressure below 140/90 mm Hg.
- Only 16% of individuals with high cholesterol levels use statins.
- Just 39% of people with Type 1 or Type 2 diabetes maintain blood sugar levels below optimal thresholds.
- Routine cancer screening rates ranged between 14% and 26%, with colon cancer screening projected to avert 206,767 deaths annually if expanded to 80% coverage.
Clinicians Share Perspectives on Prevention Goals
“Treatment of high blood pressure to goal leads to longer lives and also healthier lives. This study should inspire clinicians and patients to give more attention to appropriate management of high blood pressure using both lifestyle measures and medication.”
Daniel W. Jones, M.D., FAHA
The modeling utilized criteria from major clinical frameworks, including the News Medical for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults, which sets a target treatment goal below 130/80 mm Hg. Researchers noted that while the study projects substantial life-saving potential, it does not prescribe specific policy strategies for how governments must overcome barriers to healthcare access. Non-communicable diseases account for roughly three out of five deaths globally.